| Product Code: ETC6742604 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
China import shipments of etoricoxib intermediate in 2024 continued to be dominated by Ireland, Indonesia, UK, India, and Metropolitan France. Despite a slight growth rate of 0.01% in 2024, the compound annual growth rate (CAGR) for the period 2020-2024 remained negative at -6.23%. The High Herfindahl-Hirschman Index (HHI) indicated a high concentration of imports in the market, suggesting that these top exporting countries held significant market share in China for etoricoxib intermediate.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Etoricoxib Intermediate Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Etoricoxib Intermediate Market Revenues & Volume, 2021 & 2031F |
3.3 China Etoricoxib Intermediate Market - Industry Life Cycle |
3.4 China Etoricoxib Intermediate Market - Porter's Five Forces |
3.5 China Etoricoxib Intermediate Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Etoricoxib Intermediate Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 China Etoricoxib Intermediate Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for etoricoxib as a pain management medication in China |
4.2.2 Growth in the pharmaceutical industry in China |
4.2.3 Rising awareness about the benefits of etoricoxib intermediates for pharmaceutical manufacturing |
4.3 Market Restraints |
4.3.1 Stringent regulations and quality standards in the pharmaceutical industry in China |
4.3.2 Competition from alternative pain management medications |
4.3.3 Price fluctuations in raw materials used for etoricoxib intermediate production |
5 China Etoricoxib Intermediate Market Trends |
6 China Etoricoxib Intermediate Market, By Types |
6.1 China Etoricoxib Intermediate Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Etoricoxib Intermediate Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Etoricoxib Intermediate Market Revenues & Volume, By In-House Manufacturing, 2021- 2031F |
6.1.4 China Etoricoxib Intermediate Market Revenues & Volume, By Contract Manufacturing Organizations, 2021- 2031F |
6.2 China Etoricoxib Intermediate Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 China Etoricoxib Intermediate Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.2.3 China Etoricoxib Intermediate Market Revenues & Volume, By Psoriatic Arthritis, 2021- 2031F |
6.2.4 China Etoricoxib Intermediate Market Revenues & Volume, By Acute Pain, 2021- 2031F |
6.2.5 China Etoricoxib Intermediate Market Revenues & Volume, By Others, 2021- 2031F |
7 China Etoricoxib Intermediate Market Import-Export Trade Statistics |
7.1 China Etoricoxib Intermediate Market Export to Major Countries |
7.2 China Etoricoxib Intermediate Market Imports from Major Countries |
8 China Etoricoxib Intermediate Market Key Performance Indicators |
8.1 Number of research studies on the efficacy of etoricoxib intermediates in China |
8.2 Percentage increase in the adoption of etoricoxib intermediates by pharmaceutical companies in China |
8.3 Level of investment in RD for improving the production process of etoricoxib intermediates |
9 China Etoricoxib Intermediate Market - Opportunity Assessment |
9.1 China Etoricoxib Intermediate Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Etoricoxib Intermediate Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 China Etoricoxib Intermediate Market - Competitive Landscape |
10.1 China Etoricoxib Intermediate Market Revenue Share, By Companies, 2024 |
10.2 China Etoricoxib Intermediate Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here